Global Trial Logistics Myonex's global footprint across the US, Germany, UK, and France and its focus on end-to-end clinical trial supply creates a strong opportunity to sell integrated logistics services—cold chain management, packaging, labeling, customs, serialization, and vendor consolidation—to shorten timelines and reduce costs for sponsors and CROs.

Patient Access Platform The launch of CTRx and a patient-centric global pharmacy/dispensing program signals demand for expanded patient access, payer engagement, and benefits management. A sales angle would be offered with additional patient support tooling, local pharmacy network expansion, and data-driven adherence programs across North America and Europe.

Europe Expansion Network With CTRx Europe and acquisitions expanding trial services in Europe, there is a cross-sell opportunity to sponsors and CROs for regional sourcing, centralized local drug supply, and regulatory-compliant distribution. Emphasize local pharmacy networks and sourcing capabilities to meet regional regulatory requirements.

Acquisition Powered Growth Recent acquisitions of Creapharm and SaveWay Pharmacy, plus leadership changes and HQ expansion, suggest a need for seamless post-merger integration services, IT systems harmonization, and unified project management to realize scale. Position services around integration, workflow optimization, and client onboarding for newly acquired entities.

Digital Regulatory Compliance As a HIPAA-compliant, regulated pharmaceutical service provider, Myonex can benefit from cross-sell of data security, regulatory compliance, and digital transformation services to sponsors who demand audit-ready, secure systems and robust data governance across global operations.